Three options. Only one actually works for your business.
The corporate fertility chains are a marketing wall. The independent wins on price honesty and specialty depth.
The Australian fertility market is dominated by three corporate chains (Monash IVF, Genea, and Virtus Health which owns IVF Australia, Melbourne IVF and City Fertility) plus the disruptive low-cost entrants (Adora Fertility at $5K a cycle, Newlife IVF). They outspend an independent clinic on TV, radio and Google Ads by an order of magnitude, and they own the broad 'IVF [city]' and 'fertility clinic [city]' searches. The independent clinic competing for the same patient on the same search terms is going to lose every time. The marketing job is different: it's making the per-cycle pricing transparent on every service page (the corporate chains often bury this), building the specialty positioning around the patient groups the corporate chains genuinely underweight (LGBTQ+ family, single-parent-by-choice, known-donor, surrogacy support, complex-PGT-M genetic-disease cases), and running an evidence-based, RTAC-compliant content cadence that builds trust through the 6-to-18-month decision journey patients actually go through. The patient who Googles 'IVF [city]' on day one and the patient who books a consult on day 180 are not the same person; the corporate chains capture the day-one impulse, the independent has to win the day-180 informed-decision.
Good independent fertility clinic marketing has three layers: a pricing-transparent service page library (IVF cycle, FET, IUI, egg-freezing, donor-egg, donor-sperm, surrogacy support) with published price ranges, Medicare Safety Net detail, and indicative gap fees on every page (the corporate chains often hide this and patients notice); a specialty-positioning library for the patient groups the corporate chains underweight (LGBTQ+ family, single-parent-by-choice, known-donor pathways, surrogacy support, complex-PGT-M for monogenic disease, recurrent-pregnancy-loss, low-AMH-and-DOR specialty); and an evidence-based content cadence that supports the 6-to-18-month decision journey patients actually take. Each layer is anchored by the RTAC accreditation, the FSANZ membership, and the published success-rate data (RTAC requires this for member clinics anyway). The TGA, ART Act, and state-specific surrogacy and donor-conception register rules are baked into every piece of copy.
Six agents, working in your accounts.
Account Lead, Web, SEO, Advertising, Social Media, and Content. One platform, one bill, you approve the work.
Sets the plan around the price-honesty positioning and the specialty pathways the corporate chains underweight (LGBTQ+ family, single-parent-by-choice, known-donor, complex PGT-M, low-AMH-and-DOR, recurrent-pregnancy-loss). Briefs the other agents so the pricing-transparent service pages, the specialty positioning, the AMH-baseline-workup acquisition and the evidence-based content cadence all push toward the patient who'll spend 6-to-18 months making an informed decision, not the patient who's price-shopping a single cycle.
Imports your existing site, publishes the IVF, FET, IUI, egg-freezing and donor-pathway pricing transparently on every service page (with Medicare Safety Net detail and indicative gap), builds out the specialty-pathway library (LGBTQ+ family, single-parent-by-choice, known-donor, surrogacy support, complex PGT-M), and surfaces the RTAC accreditation and FSANZ membership everywhere.
Owns whether you appear for the searches you can actually win: 'IVF cost [city]' (where price transparency beats the corporate chains), 'LGBTQ+ fertility clinic [city]', 'single-mother-by-choice donor sperm [city]', 'low AMH IVF specialist [city]', 'PGT-M [genetic disease] [city]'. HealthService schema, RTAC-accreditation markup, state-specific surrogacy and donor-conception register compliance reflected. Auto-applies low-risk fixes.
Runs Google Ads on the specialty pathways and the price-transparency searches where the corporate chains don't compete (LGBTQ+ family, single-parent-by-choice, low-AMH-and-DOR specialty, complex-PGT-M, recurrent-pregnancy-loss). Never bids on broad 'IVF [city]' or 'fertility clinic [city]' broad terms; the corporate-chain TV-funded budget owns those. A small Meta retargeting layer catches the AMH-content browser who hasn't booked the initial fertility-assessment consult.
Posts evidence-based patient-education content in your real accounts: an AMH explainer, an LGBTQ+ family-pathway-options explainer, a single-parent-by-choice donor-sperm explainer, a PGT-A-versus-PGT-M explainer, an egg-freezing-by-age post. No testimonials (RTAC and AHPRA both restrictive here), no implied success-rate guarantees, no comparative claims against other clinics. Patient stories only with explicit fresh consent and only where they don't imply outcome guarantees.
Drafts the long-form pieces that pull the consideration-stage patient through the 6-to-18-month decision journey: 'understanding your AMH and what it means for your timeline', 'the LGBTQ+ family-building options in Australia (reciprocal IVF, donor sperm, known-donor co-parenting, surrogacy)', 'what to expect from a fertility-assessment consultation', 'IVF cost in Australia in 2026, fully explained'. Two drafts a fortnight, evidence-based, in your voice.
Your first 30 days.
- Existing site imported, hosting torn down; the existing clinic-management system stays untouched
- Price-honesty-versus-corporate-chain positioning plan set by Sam against the specialty pathways the chains underweight
- Published IVF, FET, IUI, egg-freezing and donor-pathway pricing added to every service page with Medicare Safety Net detail and indicative gap
- Specialty-pathway library built out: LGBTQ+ family, single-parent-by-choice, known-donor, surrogacy support, complex PGT-M, low-AMH-and-DOR, recurrent-pregnancy-loss
- RTAC accreditation badge, FSANZ membership and published success-rate data surfaced on every relevant page
- AMH-and-baseline-workup acquisition funnel wired with a $250 fertility-assessment consult as the entry point
- State-specific surrogacy compliance and donor-conception register obligations audited and surfaced where required
- Evidence-based content cadence queued in the clinic's voice for the next fortnight, ready for two-tap approval
An independent fertility clinic doesn't win on Google Ads spend against Monash, Genea or Virtus. The corporate chains have a $20m marketing budget and they own the broad searches. The independent wins on price honesty (publishing the IVF cycle range when the corporate chains hide it behind 'request a quote'), on specialty depth (the LGBTQ+ family, single-parent-by-choice, known-donor, complex-PGT-M pathways the chains genuinely underweight), and on the evidence-based content cadence that supports the 6-to-18-month decision journey patients actually go through. The patient who Googles 'IVF [city]' on day one isn't the patient you're winning. The patient who Googles 'low AMH IVF specialist [city]' on day 180 absolutely is.
Agencies are too dear at $6k a month and most run corporate-chain-style content that doesn't fit an independent clinic. Tools are cheap but the LGBTQ+ family pathway page never gets built. In-House is the third option: for $299 a month the agents publish the pricing transparently, build the specialty positioning, run the AMH-baseline-workup acquisition, and respect RTAC, TGA and state-specific ART Act rules. Two taps to approve, minutes a day, no agency lock-in.